Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net Loss	$ 55,453,289	$ 20,368,808
Adjustments to reconcile net loss to net cash used by operating activities:
Stock based compensation	424,455	807,523
Restricted stock expense	504,650	1,137,583
Marketing stock amortization	717,174	660,232
Issuance of stock / warrants for service	0	98,605
Inventory and materials impairment	878,142	0
Intangibles Amortization	607,025	0
Depreciation	770,335	719,856
Impairment of goodwill and other intangible assets	48,959,721	0
Increase/(Decrease) in contingent liability	(8,246,000)	10,500,000
Realized and unrealized loss of marketable and other securities	33,350	(526,939)
Termination benefit	0	495,568
Extinguishment of Paycheck Protection Program Loan		(1,466,113)
Amortization of operating lease asset	863,768	922,057
Changes in operating assets and liabilities:
Accounts receivable	(116,861)	(556,116)
Deposits	284,977	261,125
Inventory	(174,479)	(135,058)
Prepaid inventory	2,939	(385,410)
Prepaid expenses and other current assets	(1,088,579)	(141,393)
Accounts payable and accrued expenses	(1,149,456)	(603,216)
Operating lease liability	(872,656)	(846,914)
Deferred revenue / customer deposits	3,723	4,478
Collection on discontinued operations accounts receivable	9,592	428,667
Deferred tax liability	0	(765,000)
Cash used by operating activities	(13,041,469)	(9,759,273)
Cash flows from investing activities:
Proceeds from sale of other investment securities	0	540,000
Purchase of other investment securities	0	(750,000)
Proceeds from sale of assets	(322,017)	0
Purchase of property and equipment	(462,221)	(311,572)
Cash provided (used) by investing activities	(784,238)	(521,572)
Cash flows from financing activities:
Proceeds from issuance of preferred stock	0	15,798,115
Note payable	(31,044)	(137,292)
Preferred dividend distribution	(3,001,003)	(1,220,610)
Cash provided by financing activities	(3,032,047)	14,440,213
Net increase (decrease) in cash	(16,857,754)	4,159,368
Cash and cash equivalents, beginning of period	26,411,424	14,824,644
Cash and cash equivalents, end of period	9,553,670	18,984,012
Interest expense	6,817	23,573
Warrants to Purchase Common Stock [Member] | Representative of the Underwriters [Member]
Non-cash financial/investing activities:
Warrants issued to representative	0	254,950
Common Stock Earnout Shares [Member]
Non-cash financial/investing activities:
Issuance of Contingent earnout shares:	$ 908,000	$ 12,596,089